Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis.

نویسندگان

  • Felicita Andreotti
  • Bianca Rocca
  • Steen Husted
  • Ramzi A Ajjan
  • Jurrien ten Berg
  • Marco Cattaneo
  • Jean-Philippe Collet
  • Raffaele De Caterina
  • Keith A A Fox
  • Sigrun Halvorsen
  • Kurt Huber
  • Elaine M Hylek
  • Gregory Y H Lip
  • Gilles Montalescot
  • Joao Morais
  • Carlo Patrono
  • Freek W A Verheugt
  • Lars Wallentin
  • Thomas W Weiss
  • Robert F Storey
چکیده

Felicita Andreotti1*, Bianca Rocca2, Steen Husted3, Ramzi A. Ajjan4, Jurrien ten Berg5, Marco Cattaneo6, Jean-Philippe Collet7, Raffaele De Caterina8, Keith A.A. Fox9, Sigrun Halvorsen10, Kurt Huber11, Elaine M. Hylek12, Gregory Y.H. Lip13, Gilles Montalescot14, Joao Morais15, Carlo Patrono2, Freek W.A. Verheugt16, Lars Wallentin17, Thomas W. Weiss11, and Robert F. Storey18, on behalf of the ESC Thrombosis Working Group

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Management of antithrombotic therapy in atrial fibrillation patientspresentingwith acutecoronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart

Management of antithrombotic therapy in atrial fibrillation patientspresentingwith acutecoronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Asso...

متن کامل

EuroThrombosis: annual meeting of the European Society of Cardiology Working Group on Thrombosis.

EuroThrombosis is the annual meeting of the European Society of Cardiology Working Group on Thrombosis. It gathers clinicians and scientists interested in clinical/experimental thrombosis. The 2011 congress was held in Oporto, Portugal, and presented an appealing program with state-of-the-art sessions on new antiplatelet/anticoagulant agents, diabetes, cellular mechanisms of thrombosis and miRNAs.

متن کامل

Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

There remains uncertainty over optimal antithrombotic management strategy for patients with atrial fibrillation (AF) presenting with an acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting. Clinicians need to balance the risk of stroke and thromboembolism against the risk of recurrent cardiac ischaemia and/or stent thrombosis and the risk of bleeding. The full c...

متن کامل

Consensus document on the radial approach in percutaneous cardiovascular interventions: position paper by the European Association of Percutaneous Cardiovascular Interventions and Working Groups on Acute Cardiac Care** and Thrombosis of the European Society of Cardiology.

Radial access use has been growing steadily but, despite encouraging results, still varies greatly among operators, hospitals, countries and continents. Twenty years from its introduction, it was felt that the time had come to develop a common evidence-based view on the technical, clinical and organisational implications of using the radial approach for coronary angiography and interventions. T...

متن کامل

Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology.

Oral antiplatelet drugs are a cornerstone of modern pharmacotherapy in cardiovascular atherothrombotic diseases. The efficacy of acetylsalicylic acid (ASA, aspirin) and clopidogrel in decreasing the risk of adverse events in coronary heart disease patients has been well established in the past 20 years. Despite chronic oral antiplatelet therapy, a number of atherothombotic events continue to oc...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • European heart journal

دوره 36 46  شماره 

صفحات  -

تاریخ انتشار 2015